
The approval of ingenol mebutate gel presents and easy-to-use option to treat actinic keratoses (AKs), but the flexibility in dosing of a treatment like imiquimod will ensure its place in the armamentarium of AK treatments, according to the professor and chairman of the department of dermatology, Mount Sinai School of Medicine, New York.